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Introduction White-Tailed Deer 
Recently, wildlife managers have had to consider Need for Control 
. 
controlling populations of wild and feral ungulates by White-tailed deer have become so overabundant in 
nonlethal means (Warren 1995). Public opposition, 
many areas of the United States that they now repre- legislative mandates, human safety concerns, or 
sent a significant problem for natural resource manag- budgetary limitations often make the application of 
ers. Warren (1991) reviewed the historical causes of 
traditional methods of hunting, controlled shooting, this problem and presented an ecological justification poisoning, or trapping-and-relocation programs for control of overabundant deer populations in 
unacceptable management alternatives. Therefore, 
national parks, In addition to ecological concerns, 
interest and research in wildlife contraception has 
overpopulated deer herds also represent a public increased dramatically in the past decade. health and safety risk and cause significant economic 
This paper will review our research and other losses in the form of crop damage, damage to land- 
published applications of contraceptives in white-tailed scape plantings, and damage from deer-vehicle 
deer (Odocoileus virginianus), feral horses (Equus collisions (Conover and Decker 1991, Curtis and 
caballus), and mountain goats (Oreamnos Richmond 1992). 
americanus) with the assumption that these methods While regulated public hunting can effectively 
must be practical, safe, and time and cost effective to control deer populations (Behrend et al, 1970), it be useful in wildlife management. We believe that two 
cannot be used as a management technique in some primary contraceptive tools have potential applicability 
areas (e.g., national or State parks and urban or 
in these species: long-acting, implantable steroids 
suburban areas). Hence, there has been great public 
and immunocontraceptive vaccines. Most Of Our work interest in contraception as a technique for controlling in this area has focused on development and evalua- deer populations in these areas. But before they will 
tion of these wildlife contraceptives and evaluation of be accepted by wildlife managers for routine use in delivery-method efficacy. deer population control programs, contraceptives must 
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be safe, effective, easily administrable, and, ideally, 
capable of lasting the reproductive lifespan of the doe 
(Matschke 1980). 
Contraceptive Steroids 
Oral administration of the synthetic progesterone 
melengestrol acetate (MA) (Roughton 1979) or the 
synthetic estrogen diethylstilbestrol (DES) (Harder and 
Peterle 1974) can inhibit ovulation in female deer, but 
these contraceptives are not practical because they 
require daily oral exposure. Microencapsulation of 
DES can extend the effective treatment interval to 
30 days, but these high doses are not readily eaten by 
deer (Matchke 1977a). 
Subcutaneous steroid implants can increase 
treatment intervals to several months or years, but 
these techniques require costly trapping and handling 
of individual deer. Silicone tubing implants containing 
MA and DES have successfully reduced reproductive 
rates in deer for 1 to 2 years (Bell and Peterle 1975). 
Matschke examined fertility control in deer with 
SilasticB implants of DES and a synthetic progestin 
(DRC-6246). Calculated release times for DES were 
1-2 years v. 3 years for DRC-6246 (Matschke 1977b); 
however, suppressed reproduction in the field lasted 
only 2 years before depletion of DRC-6246 occurred 
(Matschke 1980). 
Implants containing MA have caused infertility in 
nonpregnant captive deer for 2 years (Plotka and Seal 
1989). When the implants were applied to pregnant 
does during winter, however, pregnancy was not 
terminated, and the implants had to be removed. 
Plotka and Seal recommended that pregnant deer not 
be treated with MA implants unless pregnancy is 
terminated. It is unfortunate that these contraceptive 
steroid implants cannot be used in winter during 
pregnancy because at that time deer generally are 
easiest to bait, capture, and treat. 
Levonorgestrel (LNG) is an implantable progestin 
that provides effective, long-term (>5-year) contracep- 
tion in humans (Diaz et al. 1982). Contraception of 
deer for >5 years from one treatment may justify the 
time and cost associated with capturing and treating 
individual deer and hence increase the potential for 
providing a practical technique for contraceptive 
management of deer populations. 
Despite the potential for this deer contraceptive, 
two studies with LNG implants in captive white-tailed 
deer have shown this device to be ineffective. In the 
first study, Plotka and Seal (1989) implanted five does 
with a single homogenous silicone rod containing 
200 mg LNG, and three of the five does became 
pregnant. Plotka and Seal did not measure LNG 
concentrations, so the lack of contraception may have 
been related to the shape and matrix of the implant, 
both of which can affect steroid hormone release 
(Robertson et al. 1983). 
White et al. (1 994) also tested LNG implants in 
deer but used the technique as it is applied in humans 
(i.e., 216 mg of LNG sealed inside six small silicone 
tubes). White's team compared six v nine LNG 
implants (containing a total of 216 v. 324 mg of LNG) 
in adult 1.: fawn does. Fawns were included to deter- 
mine the effects of LNG implantation on puberty 
attainment. Despite significant release of LNG from 
both doses of implants, three of five implanted adults 
and one of two fawns that survived 2 years after 
implantation became pregnant. 
Norgestomet (NGM) is a synthetic progestin that 
has been applied successfully as a contraceptive in 
white-tailed deer (Kesler, this volume) and black-tailed 
deer (Odocoileus hemionus) (Jacobsen et al. 1995). 
This hormone originally was marketed for synchroniz- 
ing estrus in domestic livestock. Antech Laboratories, 
Inc. (Champaign, IL), has complexed 42 mg of NGM 
into silicone rods and loaded it into biobullets 
(Kreeger, this volume) for remote delivery (Kesler, this 
volume). In both species of deer, NGM was nearly 
100-percent successful in preventing pregnancies but 
it was effective for only 1 year (Jacobsen et al. 1995; 
Kesler, this volume). Therefore, annual treatments 
would be required to maintain control over deer 
reproduction. This requirement would limit the appli- 
cability of this contraceptive technique primarily to 
smaller populations and small areas where there is 
substantial control over the deer herd. 
Contraceptlves In White-Tailed Deer, 
Feral Horses. and Mountain Goats 
lmmunocontraceptives 
The basic principle of immunocontraception is to 
produce endogenous antibodies against a particular 
protein or peptide involved in the reproductive pro- 
cess. Sufficiently high antibody titers disrupt the 
function of the protein and cause contraception. 
Infertility is maintained as long as antibody titer levels 
remain high. However, fertility can resume after 
exposure to the antigen has ceased and the antibody 
titers decrease (Primakoff et al. 1988). For white- 
tailed deer, the proteins that have been evaluated as 
immunocontraceptive antigens have been the oocyte 
ZP and spermatozoa plasma membrane proteins. 
lmmunocontraceptives have numerous advan- 
tages over contraceptive steroids that may make the 
former more effective and efficient for use in deer. 
lmmunocontraceptives can be delivered remotely, 
which makes them more feasible for field application 
than methods that require capture and immobilization 
of individual deer. Also, a protein-based vaccine likely 
would be deactivated if ingested orally by nontarget 
organisms, in contrast to the persistent tissue residues 
that often characterize the synthetic steroids. Diges- 
tion of the vaccine after oral ingestion also probably 
would prevent unintentional transfer to carnivores or 
humans. 
Turner et al. (1992) successfully used porcine 
zona pellucida (PZP) antigen in an immunocontraceptive 
for white-tailed deer. Turner's team vaccinated white- 
tailed does with 5,000 heat-solubilized porcine zonae 
pellucidae (64.3 pg protein) emulsified in 0.5 cm3 
Freund's Complete Adjuvant and delivered remotely in 
a 1-cm3 self-injecting dart. Booster injections of PZP 
emulsified in Freund's Incomplete Adjuvant were given 
3-6 weeks after the initial injection. Six months after 
onset of the injection scheme, the does were bred to a 
healthy buck of known fertility. None of the ZP-treated 
does but six of seven (86 percent) of the control does 
produced fawns. 
The requirement of multiple booster injections 
limits the practicality of using this contraceptive 
vaccine in free-ranging deer populations. However, 
recent advances in research with PZP include micro- 
encapsulation of the booster vaccinations, which 
allows release of the booster over a period of weeks 
or months so that only 1 vaccinationlyear is required 
(J. F. Kirkpatrick, pers. comm.; Stevens et al. 1992). 
Several different sperm proteins also have been 
considered for use in immunocontraceptive vaccines 
(Naz and Menge 1990). Antisperm vaccination may 
cause infertility in the male or female. In the male, 
antisperm antibodies may cause an autoimmune 
response to the sperm, thus resulting in infertility 
(Mathur et al. 1988). Treating bucks in a free-ranging 
deer population with an antisperm vaccine would have 
limited effect on the reproductive rate of the herd 
because deer are polygynous breeders. However, 
applying an antisperm vaccine may be more practical 
if males and females do not have to be distinguished 
prior to treatment. 
In the female, antisperm antibodies may cause 
agglutination of sperm (reviewed in Shulman 1986), 
reduced penetration of sperm through the cervical 
mucus (Clarke 1988), or altered sperm binding to the 
zona pellucida (Naz et al. 1992). Antisperm vaccines 
also may be "self-boosted" (i.e., additional exposure 
and boosting of the immunity against sperm may 
occur with each insemination). Some women with 
spontaneous sperm-antibody titers have reduced titers 
following the use ot condoms, wh~ch probably function 
to prevent boosting from sperm in the vagina (reviewed 
in Shulman 1986). Thus, if antisperm vaccines are 
self-boosting, they may be more practical for field 
application than multiple booster vaccinations of 
antiporcine ZP vaccines. 
Very little research exists on the use of antisperm 
vaccines in deer. To date, our research laboratory has 
presented the only data available on antisperm 
vaccines for deer (White et al. 1993). We developed 
antisperm vaccines using anterior acrosomal sperm 
plasma membranes from deer, bull, and boar sperm. 
These vaccines were injected into adult does, from 
which blood samples were collected for antibody titer 
analysis. High antisperm antibody titers occurred in 
does injected with antisperm vaccines made from all 
species tested. However, antibody recognition of deer 
sperm was greatest in those does injected with either 
deer or boar sperm. Despite high antibody titers that 
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persisted for at least 11 months after immunization, 
the does treated in this preliminary trial became 
pregnant. 
Feral Horses 
Need for Control 
Feral horses occupy extensive areas of public land in 
the United States. Historically, these herds were 
controlled by local citizens who captured wild horses 
for use as beasts of burden, in pet food, and as rodeo 
stock. In 1971, the Wild Free-Roaming Horse and 
Burro Act (Public Laws 86-234 and 92-1 95) specifi- 
cally eliminated these uses and required Federal 
agencies to control feral horses through capture and 
adoption (Wagner 1983). The adoption program has 
been very costly and unsuccessful. The cost of 
capture and adoption of each feral horse ranges from 
$300 (Turner and Kirkpatrick 1986) to more than 
$1,800 (Godfrey and Lawson 1986). In 1985, the 
Federal Government spent more than $5 million to 
remove and maintain up to 18,000 feral horses and 
burros through the "Adopt-a-Horse" program (Boyles 
1986). Many of the horses captured were older 
stallions and were not in demand by potential adopters 
(Slade and Godfrey 1982). Clearly, alternative tech- 
niques for managing feral horse populations are 
needed. 
Public sentiment and interest in feral horses is 
extremely high. This fact has led to the tremendous 
amount of political support this species has received. 
Visitors to national wildlife refuges and national parks 
that contain feral horses are very interested in observ- 
ing these animals. Yet the agencies charged with 
managing these herds are faced with a dilemma: how 
to control the feral horse populations so as to mini- 
mize the effects of overgrazing on native vegetative 
communities and still meet public interest needs and1 
or comply with the Wild Free-Roaming Horse and 
Burro Act in a manner that is logistically and fiscally 
feasible. 
Garrott (1991) and Garrott et al. (1992) evalu- 
ated the potential and economic feasibility of fertility 
control for managing feral horse populations. Based 
on their simulation analyses, Garrott and coworkers 
concluded that contraceptives could reduce substan- 
tially the number of horses that would have to be 
removed from Federal lands each year. Thus, fertility 
control may represent an effective alternative for feral 
horse population control that may be more economi- 
cally feasible than maintenance and placement of 
excess horses in the Adopt-a-Horse programs. 
Contraceptive Steroids 
The harem breeding structure of feral horses, in which 
a dominant stallion breeds most of the mares in a 
particular harem, permits the use of male-based 
wildlife contraception management programs for this 
species. Turner and Kirkpatrick (1982) administered a 
microencapsulated form of testosterone propionate 
(MTP, given intramuscularly) to feral stallions. Foal 
counts were reduced to 0.07 foalimare for MTP- 
treated bands compared to 0.37 for mares in control 
bands. The investigators also observed no differ- 
ences in stallion behavior parameters, such as scent 
marking in response to mare elimination marking, 
mounting, or copulation. The primary advantage to 
this type of treatment was that the fertility of an entire 
herd could be controlled through the treatment of a 
single stallion. Disadvantages included the fact that 
immobilization of the stallion and multiple injections 
were required, resulting in high cost and hard work. 
In a subsequent study, Kirkpatrick and Turner 
(1987 unpubl.; also cited in Turner and Kirkpatrick 
1991) used MTP to treat feral stallions in a different 
population, each with a harem of proven fertility. In 
this study, the stallions were treated remotely instead 
of being immobilized. During the 5 years prior to 
treatment, harem fertility rate ranged from 42 to 50 
percent; the year after MTP treatment, the fertility rate 
averaged 28.9 percent, compared to 45.4 percent for 
control harems during the same year. This method of 
contraception would require annual treatments and 
probably would be less effective in bands having 
sexually mature subordinate stallions or a high degree 
of movement by mares between harems. 
Feral mares also have been treated with chemi- 
cal contraceptives. Plotka et al. (1988) used silicone 
implants with estradiol and/or progesterone to inhibit 
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ovulation. Plotka's team observed greater levels of 
serum progesterone and estradiol for at least 21 
weeks in treated mares but no reduction in ovulation 
or conception. In a subsequent study, Plotka et al. 
(1 992) used silicone implants containing 
ethinylestradiol, estradiol 17-beta, or progesterone. 
The higher dosages of ethinylestradiol resulted in 
contraceptive rates of at least 88 percent for 3 years, 
with an estimated efficacy period up to 5 years. 
Contraception occurred regardless of route of implant 
delivery (subcutaneous, intramuscular, or intraperito- 
neal). 
In another study, microencapsulated 
norethisterone (MNET, a synthetic progestin) was 
administered by remote delivery to six feral mares of 
proven fertility (Kirkpatrick and Turner 1987 unpubl., 
Turner and Kirkpatrick 1991). No contraceptive effect 
from this treatment was detected, which supported the 
results of Plotka et al. (1988) for progesterone. 
Applications of microencapsulated steroids have 
a number of practical limitations. The microencapsu- 
lated suspension tends to settle out and clump if not 
delivered within 10 minutes of mixing (Turner and 
Kirkpatrick 1991). In addition, remote delivery of the 
suspension via barbless or microbarbed darts, which 
ultimately fall out of the animal, represents a potential 
for environmental contamination from lost or unrecov- 
ered darts. The method also necessitates careful 
calculation of velocity and trajectory in order to pre- 
vent rebound of the dart (Turner and Kirkpatrick 1991). 
lmmunocontraceptives 
For feral horses, the proteins that have been evalu- 
ated as immunocontraceptive antigens have been 
hormones, the oocyte zona pellucida, and spermato- 
zoa plasma membrane proteins. The only hormone 
used as an antigen for equine immunocontraception 
thus far has been luteinizing hormone-releasing 
hormone (LHRH, also referred to as gonadotropin- 
releasing hormone or GnRH). This hormone is a 
decapeptide released from the hypothalamus. The 
immunogenicity of peptides generally is low; therefore, 
LHRH must be conjugated to a larger protein to 
increase the response by the immune system. 
Safir et al. (1987) used LHRH conjugated to 
human serum albumin (HSA) and combined with 
Freund's Complete Adjuvant as an immunocontra- 
ceptive vaccine to inhibit ovulation in captive mares. 
After multiple booster injections, three of five mares 
immunized against LHRH failed to ovulate for at least 
5 months (duration of the study), whereas five of five 
untreated control mares ovulated. Inhibition of 
folliculogenesis and ovulation was related directly to 
LHRH antibody titers. 
Field application of an LHRH immunocontra- 
ceptive vaccine has been evaluated in feral horses. 
Goodloe (1991) used a vaccine composed of LHRH 
(15 mg immunogenic activity) conjugated to keyhole 
limpet hematocyanin (KLH) and mixed with one of two 
adjuvants, either alum (AP) or Ribi ImmunoChem's 
triple adjuvant (TA; 100 mg each monophosphoryl lipid 
A, trehalose dimycolate, and Bacillus Calmette-Guerin 
cell-wall skeleton). Initially, captive domestic mares 
were given the vaccine as a means of monitoring 
antibody titer levels. Vaccines were prepared in a 
microencapsulated form for the first year of study in 
captive mares; biobullet delivery was used for the 
second year. The microencapsulated vaccine was 
designed to release one dose immediately upon 
injection, one dose in 2-3 months, and a final dose in 
6-9 months. The microencapsulated vaccines could 
not be delivered via biobullet because of its limited 
payload capacity (300 mg). 
During the first year of the study using microen- 
capsulation, the vaccine with the TA adjuvant pro- 
duced higher antibody titers than did the vaccine with 
the AP adjuvant (Goodloe 1991). Three of the four 
mares treated with the TA form of the vaccine ovulated 
an average of 11 1 days after initial treatment, com- 
pared to a mean of 44 days for control mares. Thus, 
this treatment delayed but did not significantly inhibit 
ovulation. Microencapsulated vaccine also resulted in 
swelling or an abscess at the injection site of each 
mare. 
During the second year of study, the same mares 
were boosted remotely with a single biobullet. Although 
it did not stimulate antibody production sufficient to 
inhibit ovulation, this mode of vacination did not result 
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in abscess formation. Overall, there were no signifi- 
cant differences between treatment and control mares 
in terms of date of first ovulation, number of ovula- 
tions, or percentage of mares that became pregnant. 
Goodloe (1991) applied the same vaccine via 
biobullet followed by one booster injection 2-3 months 
later and a second booster injection an additional 
8 months later to 21 feral mares on Cumberland 
Island, GA. The field study further substantiated the 
results from the captive mares: foal production did not 
differ between treated and untreated mares. 
The differences in success between the studies 
by Goodloe (1991) and Safir et al. (1987) could be due 
to either the type of adjuvant or conjugate used, or to 
the number of booster vaccinations given. However, 
both studies indicate that LHRH-based immuno- 
contraceptive vaccines may be expected to produce 
infertility for at most a single breeding season, which 
obviously limits the practicality of this method of 
contraception for routine use in feral horse population 
management programs. 
The oocyte ZP also has been used as an immuno- 
gen for contraception in horses. Liu et al. (1989) used 
a series of four vaccinations (given at 2- to 4-week 
intervals) with heat- solubilized porcine ZP (64.3 kg) 
and either aluminum hydroxide gel or Freund's Com- 
plete Adjuvant. Ten feral mares were vaccinated and 
released into their natural territory, known to contain 
fertile stallions. Eight months later, the mares were 
recaptured, and their pregnancy status was deter- 
mined by rectal palpation. Four domestic mares also 
were treated and monitored in captivity. Contraception 
occurred in 12 of the 14 (86 percent) fertile mares 
studied. 
Subsequently, Kirkpatrick et al. (1990) evaluated 
the applicability of this porcine ZP vaccine to feral 
horse populations on Assateague Island, MD. The 
investigators selected sexually mature mares with 
known breeding histories; 26 mares were treated with 
the porcine ZP vaccine, six control mares were 
injected with phosphate buffer and adjuvant, and 
11 mares served as untreated controls. The vaccine 
contained 5,000 heat-solubilized porcine zonae 
pellucidae (64.3 pg protein) emulsified with equal 
volumes of Freund's Complete or Incomplete Adju- 
vant. An initial and two booster vaccinations were 
delivered remotely using self-injecting plastic syringe 
darts tipped with barbless needles. 
Of the 26 porcine ZP-treated mares, 3 developed 
abscesses at the injection site after the third vaccina- 
tion (Kirkpatrick et al. 1990). At the time of initial 
injection, 14 of the 26 mares (57.6 percent) were preg- 
nant, and all these gave birth to live foals 1-3 months 
after the final injection. Similarly, two of the six control 
mares produced live foals that same year. In the year 
after vaccination, the foaling rate for mares treated 
with porcine ZP was significantly lower the year after 
treatment (3.8 percent) compared to the 2 years prior 
to treatment (53.8 percent). In addition, foaling rates 
were significantly lower for the 26 mares treated with 
porcine ZP in the year after treatment (3.8 percent) 
when compared to foaling rates for the six control 
mares (50 percent) or the 11 untreated mares 
(45.4 percent). 
Kirkpatrick et al. (1990) had difficultly in relocat- 
ing all mares they initially injected. Of those that were 
relocated, some had become very wary and could not 
be given booster vaccinations. Subsequent work by 
this research team has focused on developing a one- 
shot injection in which a booster vaccination is micro- 
encapsulated (J. F. Kirkpatrick, pers. comm.). 
Kirkpatrick et al. (1991) continued this study and 
gave booster vaccinations to 14 of the original 26 
mares treated with porcine ZP approximately 1 year 
following the initial treatment. Foaling data collected 
in the subsequent year indicated that foals were 
produced by 1 of 14 (7 percent) boosted mares, 3 of 6 
(50 percent) control mares, and 7 of 16 (44 percent) 
untreated mares. During a third year for the same 
study, Kirkpatrick et al. (1992) treated 10 of the mares 
boosted during the second year with another identical 
vaccination. None of the 10 mares boosted for a third 
consecutive year became pregnant, as opposed to 11 
of 20 (55 percent) control mares. The researchers 
also used intensive visual observations and urinary 
analysis to monitor behavioral estrus and ovarian 
function for seven of the treated and four of the control 
mares. Based on these analyses, only two of the 
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seven treated mares demonstrated ovulatory cycles. 
The lack of cyclicity was thought to be due to altered 
ovarian function as has been shown to occur in other 
species given a similar vaccine (Skinner et al. 1984, 
Dunbar et al. 1989). 
Thus, the porcine ZP vaccine has been shown to 
be very effective as an immunocontraceptive in feral 
horses. However, the formulation of porcine ZP 
vaccine used by Kirkpatrick et al. (1990, 1991, 1992) 
has certain characteristics that may limit its practical 
applicability in the field. Use of Freund's Complete 
Adjuvant in the vaccine is a distinct disadvantage. 
Most approved veterinary vaccination protocols do not 
permit the use of Freund's Complete Adjuvant in any 
applications other than small-scale, experimental 
trials. Therefore, a porcine ZP vaccine containing this 
adjuvant probably will not be approved for routine use 
in feral horse population-control programs. In addi- 
tion, because Freund's Adjuvant cannot be lyophilized, 
a vaccine incorporating it must be administered as a 
liquid in a syringe dart as opposed to the biobullet. 
Because of the above-mentioned concerns over 
the use of Freund's Adjuvant, Willis et al. (1994b) 
evaluated the use of an alternative formulation of the 
porcine ZP vaccine for horse contraception. The Willis 
team's formulation contained 200 pg of porcine ZP 
antigen and 500 pg of synthetic trehalose 
dicotynomycolate glycolipid (Ribi ImunoChem Research, 
Inc., Hamilton, MT) as an adjuvant. This porcine ZP 
vaccine formulation was lyophilized and packed into 
biobullets (Kreeger, this volume) for remote delivery to 
captive horses. Goodloe (1991) had previously 
documented the efficacy of this method for remote 
delivery of immunocontraceptives to free-ranging feral 
horses. Willis et al. (199413) treated four mares with 
an initial and one booster vaccination separated by 
1 month. Four control mares were injected with 
biobullets containing only the adjuvant. All mares 
were bled for antibody titer analysis and bred to a 
sexually mature stallion at each estrous period 
through two complete breeding seasons. The control 
mares had no titer levels and conceived during their 
first estrous period, in contrast to three of the four 
mares treated with porcine ZP, which had high 
antiporcine ZP titers and did not conceive. The fourth 
treated mare had lower titer levels and was fertile, but 
she too became infertile after administration of a 
subsequent booster vaccination. 
Willis et al. (1994b) monitored antibody titer 
levels and infertility during the breeding season the 
year after initial treatment and, despite not having 
received a booster vaccination in the second year of 
this study, all of the treated mares continued to have 
high titer levels and were infertile. The greater poten- 
tial duration of contraceptive effect apparent for this 
porcine ZP vaccine formulation may greatly improve 
its field applicability compared to other formulations 
that require annual booster vaccinations. 
Sperm proteins also have potential for being 
used as antigens in immunocontraceptive vaccines, 
although relatively little research has been done in this 
area with horses. The most extensively characterized 
sperm immunocontraceptive thus far was developed 
by Naz et al. (1 984). Naz and coworkers developed a 
monoclonal antibody (MA-24) in the mouse that 
specifically recognized a glycoprotein found only on 
the postacrosome, midpiece, and tail of sperm. This 
glycoprotein was termed fertilization antigen 1 (FA-1). 
FA-1 was determined to be nonspecies specific 
because the MA-24 antibody cross-reacted with 
sperm from mice, rabbits, rhesus monkeys, and bulls 
(Naz and Menge 1990). The MA-24 antibody appar- 
ently causes contraception by blocking sperm-egg 
binding. Treatment of sperm with either the MA-24 
antibody or antiserum against FA-1 prior to insemina- 
tion significantly reduced in vitro fertilization rates as 
compared to untreated sperm (Naz 1987). In addition, 
female rabbits immunized with purified FA-1 had 
significantly lower in vivo fertilization rates (1 4.7 
percent) as compared to control rabbits (91.7 percent) 
(Naz et al. 1986). 
The only research published to date in the area of 
sperm plasma-membrane protein immunocontraception 
in horses was done in our research laboratory (Willis 
1993, Willis et al. 1994a). We developed antisperm 
vaccines using plasma membrane proteins from 
porcine and equine sperm. These vaccines were 
adjuvented with synthetic trehalose dicorynomycolate 
glycolipid, lyophilized, and administered via biobullet 
to two captive mares. Four mares served as controls 
Contraception in Wildlife Management 
and received biobullets containing only the adjuvant. 
All mares were bred to a fertile stallion, and blood 
samples were collected for antibody titer analysis. 
High antisperm antibody titers were detected in the 
treated mares, but no significant differences occurred 
in conception: one of two treated mares became 
pregnant compared to three of four controls. 
Mountain Goats 
Need for Control 
The mountain goat is a native species in some moun- 
tainous habitats in North America. However, there is 
debate over its status as a native species on the 
Olympic Peninsula of western Washington. National 
Park Service (NPS) scientists in Olympic National 
Park maintain that the mountain goats were artificially 
introduced into this park by humans in the 1920's 
(Moorhead and Stevens 1982). Conversely, Lyman 
(1988) argued that this species may have become 
locally extinct on the Olympic Peninsula prior to the 
first biological surveys in the late 19th and early 20th 
centuries. If Lyman is correct, mountain goats may 
not be exotics in the park. 
The status (i.e., native or exotic) of mountain 
goats in this park is very important because NPS 
management policies encourage the elimination of 
exotic species that may threaten the survival of native 
species. Ecological research conducted in the park 
has shown that fragile alpine plant communities are 
being threatened by grazing pressure from mountain 
goats (Olympic National Park 1981 and 1987). Because 
of this concern, NPS began a capture-and-removal 
program in 1981 to reduce or eliminate mountain 
goats from the park (Houston and Stevens 1988, 
Carlquist 1990, Houston et al. 1991). This removal 
program has been very costly (as much as $900- 
1,000 per goat removed) (Houston et al. 1991). 
Therefore, NPS has experimented with fertility control 
as a more cost-effective means of controlling moun- 
tain goats in the park. Lethal removal of mountain 
goats, while acceptable and cost effective for control 
of feral goats in some countries (Parkes 1990), is very 
controversial in the United States. 
Contraceptive Steroids 
In deciding which contraceptive techniques to evalu- 
ate, NPS scientists considered a number of criteria: 
ease of application in the field, safety to goats and 
humans, potential for treating a large proportion of the 
population, duration of efficacy, and cost. In an 
experimental evaluation of contraceptive and steriliza- 
tion methods to control goats in Olympic National 
Park, Hoffman and Wright (1990) captured and placed 
silicone implants containing MA in the neck region of 
11 female mountain goats. The investigators also 
captured five male goats in a different portion of the 
park and injected their epididymis with a sclerosing 
agent containing lactic acid (ChemcastTM, BioCeutic 
Laboratories, Inc., St. Joseph, MO). The females 
were monitored in the field for a period of 5 years, 
during which the rate of kid production averaged 
10 percent as compared to 68 percent for a similar 
group of untreated females in the park during the 
same time period. Comparative examination of the 
treated males 2 years after treatment confirmed 
blockage of their epididymides and sterilization. 
However, visual monitoring of the area occupied by 
the males for 2 years after treatment revealed no 
change in population size or the rate of kid production 
by females. Male-based contraceptive techniques 
obviously have limited potential for success in a wild, 
polygynous species. Hoffman and Wright (1990) 
concluded that the techniques they tested might have 
potential for controlling the numbers of mountain goats 
in the park. However, the requirement that goats had 
to be captured for treatment made these techniques 
very expensive and limited their widespread opera- 
tional application over a larger portion of the park. In 
addition, captures by helicopter, which were manda- 
tory for capturing mountain goats in the park, were 
discouraged in 1990 by the U.S. Department of the 
Interior's Office of Aircraft Safety after a risk assess- 
ment revealed that the goat capture procedures 
represented a significant human safety hazard (Tuler 
et al. 1992). 
Contraceptives in White-Tailed Deer, 
Feral Horses, and Mountain Goats 
Immunocontraceptives 
No published research is available on immunocontra- 
ceptives in mountain goats. lmmunocontraception may 
have potential for application in Olympic National 
Park. However, logistical and fiscal limitations associ- 
ated with fieldwork in this park will necessitate long- 
acting (preferably permanent) immunocontraceptives 
that can be delivered remotely via a biobullet or 
syringe dart shot from a helicopter. Field application 
of remotely delivered immunocontraceptives from a 
helicopter in the rugged, mountainous terrain of 
Olympic National Park likely represents the most 
difficult situation for contraceptive management of a 
wildlife population. 
Conclusions and Practical 
Applicability 
The above literature review demonstrates that several 
available contraceptive techniques are effective in 
individually treated deer, horses, and mountain goats. 
Additional literature on the application of contracep- 
tives in other species has been reviewed by Bomford 
(1990) and Kirkpatrick and Turner (1991). Despite the 
success of some contraceptives in individually treated 
animals or in captive situations, management of 
wildlife populations with contraceptives may be 
infeasible if they are not practically applicable in the 
field. More research is needed to document that 
contraceptives can be effective when applied as a 
management technique at the population level. 
Garrott (1995) published results of a study that used 
computer simulations to consider the prospects of 
controlling wildlife populations with contraceptive 
techniques. However, nobody will know the true 
potential for contraceptive management until these 
techniques are tested under real-world conditions 
where feasibility of field applicability, interactions 
among ecological factors and processes, the potential 
population-level efficacy of treatments, and consider- 
ations of time and cost efficiency become paramount 
to the success or failure of any program for wildlife 
contraception. 
A number of important practical questions exist 
relative to the potential applicability of contraception in 
wildlife management. Aside from the questions about 
the efficacy of the particular contraceptive agent, its 
duration of effect, and its safety to treated animals are 
important questions relative to the potential effects of 
the agent on the ecological food chain. In this regard, 
contraceptive vaccines likely will be safer than contra- 
ceptive steroids. Nonetheless, research is needed to 
determine the extent to which contraceptive vaccines 
may be effective after ingestion by nontarget organ- 
isms, including humans. lmmunocontraceptives will 
not be approved by Federal and State regulatory 
agencies for routine field implementation in wildlife 
management programs until these potential secondary 
effects are documented as being environmentally 
insignificant. 
Interactions among ecological processes will 
likely exert a great effect on the success of wildlife 
contraceptive-management programs. Reduced 
reproduction by females treated with contraceptives 
may provide greater chances for survival of offspring 
born to other untreated females in the population. In 
other words, there may be a compensatory increase in 
juvenile survival. Additionally, reductions in a particu- 
lar population because of reduced reproduction could 
be offset by immigration of individuals from areas 
surrounding the treatment area. 
Time and cost efficiency are extremely important 
issues when considering wildlife contraceptive- 
management programs. The contraceptive agents 
themselves may be economical, but the personnel and 
operating expenses associated with delivering contra- 
ceptives to significant proportions of individuals in a 
wildlife population likely will be cost prohibitive. State 
wildlife agencies obtain much of their funding from 
sales of hunting and fishing licenses and Federal aid 
funds for wildlife restoration (e.g., the Pittman- 
Robertson tax). Therefore, it may be inappropriate for 
these agencies to use these revenues for contracep- 
tive management programs. Alternate State, Federal, 
municipal, or private funds probably will be required to 
support contraceptive management programs. 
Contraception in Wildlife Management 
The nature of the wildlife management profes- 
sion has changed greatly in the United States during 
the past few decades. Societal changes have altered 
the opinions and expectations of the public we serve. 
Wildlife biologists and managers are entrusted by the 
public with the responsibility of managing our wildlife 
resources. Nonlethal techniques for wildlife popula- 
tion management are increasingly demanded by the 
public in some situations. The potential for contracep- 
tion to become a successful wildlife population man- 
agement technique in certain publicly sensitive 
situations is great. Wildlife biologists have a profes- 
sional obligation to consider all possible techniques for 
use in wildlife population management. 
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